In our data, serum PAI-1 concentrations increased with the rise of resistin levels unexplained by CV risk in both groups—CKD (p = 0.038) and participants with eGFR ≥ 60 mL/min/1.73 m2 (p < 0.001). The gene discussed is RETN; the disease is chronic kidney disease.